To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence
NCT06360523
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
368
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST:
AI modal
DIAGNOSTIC_TEST:
Standard review
Sponsor
Chinese University of Hong Kong